Genotype-specific Redox Chemotherapy Targeting NQO1*2 Breast Cancer

被引：0
|
作者：
Cabello, Christopher M. [1 ]
Lamore, Sarah D. [1 ]
Bair, Warner B., III [1 ]
Bause, Alexandra S. [1 ]
Azimian, Sara [1 ]
Wondrak, Georg T. [1 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2009年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [21] An antisense RNA promotes breast cancer metastasis via upregulation of NQO1
    Nature Cancer, 2023, 4 : 592 - 593
  • [22] A Model for NAD(P) H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy
    Begleiter, Asher
    El-Gabalawy, Nadia
    Lange, Laurie
    Leith, Marsha K.
    Guziec, Lynn J.
    Guziec, Frank S., Jr.
    DRUG TARGET INSIGHTS, 2009, 4 : 1 - 8
  • [23] Overexpression of NAD(P)H: quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones
    Glorieux, Christophe
    Sandoval, Juan Marcelo
    Dejeans, Nicolas
    Ameye, Genevieve
    Poirel, Helene Antoine
    Verrax, Julien
    Buc Calderon, Pedro
    LIFE SCIENCES, 2016, 145 : 57 - 65
  • [24] Benzene, NQO1, and genetic susceptibility to cancer
    Smith, MT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 7624 - 7626
  • [25] NQO1*2 genotype predicts poor survival in NSCLC patients receiving radiation and chemotherapy as part of E3590
    Kolesar, J
    Vangel, M
    McLeod, H
    Schiller, J
    Johnson, D
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S43 - S43
  • [26] NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
    Rainer Fagerholm
    Barbara Hofstetter
    Johanna Tommiska
    Kirsimari Aaltonen
    Radek Vrtel
    Kirsi Syrjäkoski
    Anne Kallioniemi
    Outi Kilpivaara
    Arto Mannermaa
    Veli-Matti Kosma
    Matti Uusitupa
    Matti Eskelinen
    Vesa Kataja
    Kristiina Aittomäki
    Karl von Smitten
    Päivi Heikkilä
    Jiri Lukas
    Kaija Holli
    Jirina Bartkova
    Carl Blomqvist
    Jiri Bartek
    Heli Nevanlinna
    Nature Genetics, 2008, 40 : 844 - 853
  • [27] NAD(P)H:quinone oxidoreductase 1 NQO1☆2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
    Fagerholm, Rainer
    Hofstetter, Barbara
    Tommiska, Johanna
    Aaltonen, Kirsimari
    Vrtel, Radek
    Syrjakoski, Kirsi
    Kallioniemi, Anne
    Kilpivaara, Outi
    Mannermaa, Arto
    Kosma, Veli-Matti
    Uusitupa, Matti
    Eskelinen, Matti
    Kataja, Vesa
    Aittomakii, Kristiina
    von Smitten, Karl
    Heikkilae, Paeivi
    Lukas, Jiri
    Holli, Kaija
    Bartkova, Jirina
    Blomqvist, Carl
    Bartek, Jiri
    Nevanlinna, Heli
    NATURE GENETICS, 2008, 40 (07) : 844 - 853
  • [28] Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen
    Grim, J.
    Jandik, P.
    Slanska, I.
    Dolezelova-Brcakova, E.
    Fuksa, L.
    Ryska, A.
    Knizek, J.
    Petera, J.
    Micuda, S.
    Hornychova, H.
    FOLIA BIOLOGICA, 2012, 58 (05) : 185 - 192
  • [29] β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer
    Qadir, Muhammad Imran
    Iqbal, Muhammad Shahid
    Khan, Rimsha
    CURRENT CANCER DRUG TARGETS, 2022, 22 (07) : 537 - 540
  • [30] NQO1 expression correlates inversely with NFκB activation in human breast cancer
    Maral Jamshidi
    Jirina Bartkova
    Dario Greco
    Johanna Tommiska
    Rainer Fagerholm
    Kristiina Aittomäki
    Johanna Mattson
    Kenneth Villman
    Radek Vrtel
    Jiri Lukas
    Päivi Heikkilä
    Carl Blomqvist
    Jiri Bartek
    Heli Nevanlinna
    Breast Cancer Research and Treatment, 2012, 132 : 955 - 968
12345